SE461732B - Antitumoerfoereningar av kinazolintyp - Google Patents

Antitumoerfoereningar av kinazolintyp

Info

Publication number
SE461732B
SE461732B SE8200526A SE8200526A SE461732B SE 461732 B SE461732 B SE 461732B SE 8200526 A SE8200526 A SE 8200526A SE 8200526 A SE8200526 A SE 8200526A SE 461732 B SE461732 B SE 461732B
Authority
SE
Sweden
Prior art keywords
formula
ethyl
compound
compounds
give
Prior art date
Application number
SE8200526A
Other languages
English (en)
Swedish (sv)
Other versions
SE8200526L (sv
Inventor
W E Kreighbaum
W T Comer
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8200526L publication Critical patent/SE8200526L/xx
Publication of SE461732B publication Critical patent/SE461732B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8200526A 1981-03-06 1982-01-29 Antitumoerfoereningar av kinazolintyp SE461732B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/241,317 US4343940A (en) 1979-02-13 1981-03-06 Anti-tumor quinazoline compounds

Publications (2)

Publication Number Publication Date
SE8200526L SE8200526L (sv) 1982-09-07
SE461732B true SE461732B (sv) 1990-03-19

Family

ID=22910195

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200526A SE461732B (sv) 1981-03-06 1982-01-29 Antitumoerfoereningar av kinazolintyp

Country Status (31)

Country Link
US (1) US4343940A (es)
JP (1) JPS57158780A (es)
KR (1) KR880001852B1 (es)
AR (1) AR231138A1 (es)
AT (1) AT380476B (es)
AU (1) AU556099B2 (es)
BE (1) BE891936A (es)
CA (1) CA1163995A (es)
CH (1) CH647776A5 (es)
CY (1) CY1371A (es)
DE (1) DE3203770C2 (es)
DK (1) DK159442C (es)
ES (1) ES8304095A1 (es)
FI (1) FI71559C (es)
FR (1) FR2501207B1 (es)
GB (1) GB2094295B (es)
GR (1) GR75903B (es)
HK (1) HK4588A (es)
HU (1) HU189997B (es)
IE (1) IE52385B1 (es)
IL (1) IL64875A0 (es)
IT (1) IT1154272B (es)
KE (1) KE3715A (es)
LU (1) LU83903A1 (es)
NL (1) NL8200473A (es)
NZ (1) NZ199576A (es)
PH (1) PH18529A (es)
PT (1) PT74394B (es)
SE (1) SE461732B (es)
SG (1) SG30787G (es)
YU (1) YU42031B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US5030635A (en) * 1990-02-14 1991-07-09 Ortho Pharmaceutical Corporation 6-7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
USRE37650E1 (en) 1991-05-10 2002-04-09 Aventis Pharmacetical Products, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5714493A (en) * 1991-05-10 1998-02-03 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
US5804396A (en) * 1994-10-12 1998-09-08 Sugen, Inc. Assay for agents active in proliferative disorders
TW321649B (es) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
AU5343096A (en) * 1995-04-27 1996-11-18 Zeneca Limited Quinazoline derivatives
DE69618587T2 (de) * 1995-06-07 2002-08-29 Sugen, Inc. Chinazoline und pharmazeutische zusammensetzungen
WO1997017329A1 (fr) * 1995-11-07 1997-05-15 Kirin Beer Kabushiki Kaisha Derives de quinoline et derives de quinazoline inhibant l'autophosphorylation d'un recepteur de facteur de croissance originaire de plaquettes, et compositions pharmaceutiques les contenant
US7119174B2 (en) * 1995-12-18 2006-10-10 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
IL125686A (en) 1996-02-13 2002-11-10 Zeneca Ltd Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
WO1997032856A1 (en) 1996-03-05 1997-09-12 Zeneca Limited 4-anilinoquinazoline derivatives
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
PT948604E (pt) * 1996-12-11 2004-10-29 Univ New York Medical Ct Produtos e metodos relacionados com pyk2
US6818440B2 (en) 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6228641B1 (en) 1997-05-20 2001-05-08 Sugen, Inc. Diagnosis and treatment of PTP04 related disorders
US6342593B1 (en) 1997-06-11 2002-01-29 Sugen, Inc. Diagnosis and treatment of ALP related disorders
US7115710B2 (en) * 1997-06-11 2006-10-03 Sugen, Inc. Diagnosis and treatment of PTP related disorders
US6388063B1 (en) * 1997-06-18 2002-05-14 Sugen, Inc. Diagnosis and treatment of SAD related disorders
EP1049786A2 (en) * 1998-01-21 2000-11-08 Sugen, Inc. Human orthologues of wart
US6680170B2 (en) * 1998-04-14 2004-01-20 Sugen, Inc. Polynucleotides encoding STE20-related protein kinases and methods of use
AU4317399A (en) 1998-05-28 1999-12-13 Parker Hughes Institute Quinazolines for treating brain tumor
US6800649B1 (en) * 1998-06-30 2004-10-05 Parker Hughes Institute Method for inhibiting c-jun expression using JAK-3 inhibitors
MXPA01001893A (es) 1998-08-21 2002-04-24 Parker Hughes Inst Derivados de quinazolina.
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
US6258820B1 (en) * 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
US7364866B2 (en) * 1999-10-22 2008-04-29 Pharmacia & Upjohn Company Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
US6835546B1 (en) * 1999-10-22 2004-12-28 Pharmacia & Upjohn Company Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
US20030162223A1 (en) * 1999-10-22 2003-08-28 Lowery David E. Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
IL149034A0 (en) 1999-11-05 2002-11-10 Astrazeneca Ab Quinazoline derivatives as vegf inhibitors
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
EP1265925A2 (en) * 2000-02-23 2002-12-18 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
KR100858069B1 (ko) * 2000-04-07 2008-09-22 아스트라제네카 아베 퀴나졸린 화합물류
US20050069976A1 (en) * 2001-02-14 2005-03-31 Peter Lind Protein-coupled receptor
US20050239852A1 (en) 2002-08-02 2005-10-27 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
NZ546645A (en) * 2003-10-23 2010-02-26 Ab Science 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors
CA2603826C (en) 2005-04-04 2013-03-12 Ab Science Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
US8246966B2 (en) * 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
KR101129868B1 (ko) 2006-10-04 2012-04-12 화이자 프로덕츠 인코포레이티드 칼슘 수용체 길항제로서의 피리도［4,3-ｄ］피리미딘-4(3Ｈ)-온 유도체
EP2088863A2 (en) * 2006-11-22 2009-08-19 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
US20110008347A1 (en) * 2006-12-01 2011-01-13 Agency For Science ,Technology And Research Cancer-related protein kinases
KR20210043016A (ko) 2011-03-04 2021-04-20 뉴젠 세러퓨틱스 인코포레이티드 알킨 치환된 퀴나졸린 화합물 및 그것의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3298291A (en) * 1965-12-28 1967-01-17 Jack D Layton Paver screed assembly
US3455920A (en) * 1967-01-13 1969-07-15 Squibb & Sons Inc 2,3-dihydro-5 and 6-substituted-2-phenyl-4(1h)-quinazolinones
US3637693A (en) * 1968-07-12 1972-01-25 Du Pont Hydroxyarylquinazolines and their use as uv-absorbers
DE2050092C3 (de) 1970-10-13 1980-04-24 Bayer Ag, 5090 Leverkusen Chinazolondiurethane, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
AU438472B2 (en) * 1970-12-23 1973-08-09 Sumitomo Chemical Company, Limited Quinazolinone derivatives anda process for production thereof
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions
JPS6011032B2 (ja) 1975-12-16 1985-03-22 大鵬薬品工業株式会社 ２―置換―５―フルオルピリミジン―４―オン誘導体の製造法

Also Published As

Publication number Publication date
PT74394B (en) 1984-10-22
FR2501207A1 (fr) 1982-09-10
DK50482A (da) 1982-09-07
SG30787G (en) 1988-09-16
US4343940A (en) 1982-08-10
CA1163995A (en) 1984-03-20
ATA39582A (de) 1985-10-15
YU42031B (en) 1988-04-30
CY1371A (en) 1987-08-07
FI71559C (fi) 1987-01-19
KE3715A (en) 1987-04-16
HK4588A (en) 1988-01-29
FI71559B (fi) 1986-10-10
IT1154272B (it) 1987-01-21
FI820399L (fi) 1982-09-07
IL64875A0 (en) 1982-03-31
JPS57158780A (en) 1982-09-30
DK159442C (da) 1991-03-18
DE3203770C2 (de) 1993-11-04
LU83903A1 (fr) 1982-09-13
HU189997B (en) 1986-08-28
KR830009050A (ko) 1983-12-17
NL8200473A (nl) 1982-10-01
AT380476B (de) 1986-05-26
AU556099B2 (en) 1986-10-23
PT74394A (en) 1982-03-01
GR75903B (es) 1984-08-02
IT8247713A0 (it) 1982-02-03
SE8200526L (sv) 1982-09-07
IE52385B1 (en) 1987-10-14
FR2501207B1 (fr) 1985-12-06
AU7998182A (en) 1982-09-09
DK159442B (da) 1990-10-15
ES509434A0 (es) 1983-02-16
NZ199576A (en) 1986-05-09
AR231138A1 (es) 1984-09-28
GB2094295A (en) 1982-09-15
DE3203770A1 (de) 1982-11-11
YU25682A (en) 1985-03-20
CH647776A5 (de) 1985-02-15
ES8304095A1 (es) 1983-02-16
GB2094295B (en) 1984-09-12
BE891936A (fr) 1982-07-28
KR880001852B1 (ko) 1988-09-22
PH18529A (en) 1985-08-02
IE820163L (en) 1982-09-06
JPH0337552B2 (es) 1991-06-05

Similar Documents

Publication Publication Date Title
SE461732B (sv) Antitumoerfoereningar av kinazolintyp
FI68398B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat
KR840002141B1 (ko) 벤즈옥사진 유도체의 제조방법
GB2127402A (en) Pharmaceutically active carbostyril derivatives
US4234586A (en) Nitrogen bridgehead compounds having anti-allergic effect
US4314943A (en) Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
EP0156331B1 (en) Benzofuran derivatives, processes for preparing the same and antihypertensive agents containing the same
US3637699A (en) Dialkyl-substituted-4-(hydroxyalkyl-bearing)aminoquinazolines nitrates
US4053600A (en) Tricyclic 1,2,4-triazolo-quinazolines
HU197746B (en) Process for producing xantin derivatives and pharmaceutical compositions containing them
US3971814A (en) Benzo(b)thiophene derivatives
US3538098A (en) Process for the production of coumarin derivatives
JPS6183163A (ja) 抗腫瘍剤
US4018793A (en) Benzo (b) thiophene derivatives
US3985731A (en) 2H-2-benzazepin-1,3-diones
IL37431A (en) Pharmaceutical compositions containing derivatives of thiazolino(3,2-a)pyrimidin-5-one,certain such novel derivatives and their preparation
US4075210A (en) Pyrazolo[1,5-a]pyrido[4,3-d]pyrimidin-9(4H)-one and derivatives thereof
DD215545A5 (de) Verfahren zur herstellung eines (1,2,4)triazolo (4,3-a)chin-oxalin-4-amin-derivats
Hynes et al. Synthesis of 2‐aminoquinazolines from ortho‐fluoroketones
US3757019A (en) Alkoxy-1,2,3-benzotriazine-4(3h)-ones 3 - (alpha-substituted amino-beta-alkoxybenzoxypropyl)-6,7- or 6,7,8-
US4495352A (en) Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
KR820000199B1 (ko) 아릴-알킬아민의 제조 방법
US4082770A (en) Benzo(b)thiophene derivatives
US4056526A (en) Benzo(b)thiophene derivatives
US3399195A (en) Theophylline derivatives

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8200526-5

Effective date: 19940810

Format of ref document f/p: F